about
Hematologic complications, healthcare utilization, and costs in commercially insured patients with myelodysplastic syndrome receiving supportive care.DNA methylation changes following 5-azacitidine treatment in patients with myelodysplastic syndrome.A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndromeChanging the treatment paradigm in myelodysplastic syndromes.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment strategies in myelodysplastic syndromes.
@en
Treatment strategies in myelodysplastic syndromes.
@nl
type
label
Treatment strategies in myelodysplastic syndromes.
@en
Treatment strategies in myelodysplastic syndromes.
@nl
prefLabel
Treatment strategies in myelodysplastic syndromes.
@en
Treatment strategies in myelodysplastic syndromes.
@nl
P2860
P1433
P1476
Treatment strategies in myelodysplastic syndromes.
@en
P2093
Ehab Atallah
Guillermo Garcia-Manero
P2860
P304
P356
10.1080/07357900701788122
P577
2008-03-01T00:00:00Z